Roche announced today that the European Commission has approved its innovative drug Mircera to treat anaemia associated with chronic kidney disease (CKD). The approval of Mircera results in a single ...

ZURICH, May 25 (Reuters) - Roche Holding AG's potential blockbuster drug Mircera has been cleared by European authorities, who recommended allowing sales to treat anaemia linked to kidney disease.

Please provide your email address to receive an email when new articles are posted on . Among surveyed nephrologists, familiarity with Roche’s Mircera is low, but is still second highest among six ...

Roche Holding AG received preliminary approval to sell its new anemia drug Mircera in Europe and said it expects approval in the U.S. by the end of the year, moving the Swiss company closer to ...

The approval was based on an open-label, multiple dose, multicenter, dose-finding study in 64 pediatric patients with CKD who were on hemodialysis and who had stable hemoglobin levels while previously ...

ZURICH, May 11 (Reuters) - A U.S recommendation to restrict further a group of anaemia drugs widely used by cancer patients could hit Switzerland's Roche Holding AG , which expects an approval ...

The judge refereeing the turf battle between Roche and Amgen over anemia meds has taken a time-out to consult the experts. Judge William Young said he's grappling "with complex issues" in the patent ...

The FDA has approved Roche's anemia drug Mircera, but don't look for any big new product launches soon. Last month Amgen won a patent infringement case on the therapy. And Roche is studying its ...

Researchers have successfully developed a new electrophoretic method for detecting MIRCERA and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically enhanced ...

BOSTON U.S. District Judge William Young has ordered Amgen and Roche to submit a list of names for an expert to be appointed to their trial regarding the release of Roche’s anemia drug, Mircera, in ...

Roche Pharmaceuticals quickly rejected claims that Roche planted secret molecule in Mircera which allowed for detection of the CERA class drug at the 2008 Tour de France. John Fahey, WADA president, ...

In the long battle for Amgen to prevent generic drug company Roche Holdings from bringing its anemia drug Mircera into the US market, a federal appeals court has ruled that Roche could import its drug ...